Navigation Links
ResearchDx Launches Contract Diagnostics Organization (CDO)
Date:2/22/2011

IRVINE, Calif., Feb. 22, 2011 /PRNewswire/ -- ResearchDx announced today the official launch of the first-ever Contract Diagnostics Organization or CDO.

Recent FDA initiatives, such as the Critical Path Initiative and the Drug-Diagnostic Co-Development Concept Paper, have spurred biopharmaceutical companies' interest in biomarker research for the purpose of developing companion diagnostics. The traditional Contract Research Organization (CRO), which has focused on clinical trials for pharmaceutical products, cannot meet the need for both an in-depth knowledge of the diagnostics industry and the ability to run diagnostic tests in a clinical laboratory. Conversely, Diagnostics companies lack the ability to perform clinical testing and have an incentive to steer diagnostic development toward their existing products' technology platforms. However, ResearchDx, as a CDO, provides all of these services in an integrated, technology-independent manner that stays focused on their customers' business objectives.

"At ResearchDx, we take contract R&D for diagnostics to the next generation," states co-founder Philip Cotter.  "Our partners trust ResearchDx to provide everything they need to develop a diagnostic product, and that we make their business objectives our priority."

Dr. Philip Cotter and Dr. Mat Moore, the founders of ResearchDx, have a passion for the advancement of personalized medicine. With their team's extensive experience in managing clinical laboratories, designing and managing clinical research, and navigating the complex regulatory environment specific to diagnostics, they saw the opportunity to fill an unmet need for partnership with the biopharmaceutical and diagnostics industries.  In founding the first-ever CDO, they have achieved their vision to help biopharmaceutical companies overcome the barriers to developing diagnostic products.

About ResearchDx

ResearchDx is a Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides integrated, flexible services for the diagnostic development process – from initial assay concepts and discovery through clinical research to regulatory approval.   ResearchDx's service areas include clinical research, clinical laboratory services, diagnostic manufacturing, and consulting.

CONTACT:  Philip Cotter, +1-510-332-0477, for ResearchDx


'/>"/>
SOURCE ResearchDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System
2. Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System
3. Success Factors and Failure Points in Biopharmaceutical Product Launches
4. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
5. HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad
6. Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
7. Brainlab Launches Refreshed Website
8. Cayenne Medical, Inc. Launches AperFix® II
9. ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
10. Mylan Launches First Generic Version of Vfend® Tablets
11. PARI Respiratory Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... MARLBOROUGH, Mass. , March 28, 2017 /PRNewswire/ ... RNAi company developing innovative therapeutics that address significant ... granted a patent from the Japan Patent Office ... targeting connective tissue growth factor (CTGF) for the ... not limited to skin fibrosis and proliferative retinopathy ...
(Date:3/28/2017)... 28, 2017 The global ... 8.0 billion by 2025, according to a new study ... infectious diseases and cancer is expected to upsurge the ... over the coming years. In addition, higher number of ... allogenic stem cell therapy, due to adverse effects caused ...
Breaking Medicine Technology:
(Date:3/28/2017)... CT (PRWEB) , ... March 28, 2017 , ... ... devices, announces today that the University of Pittsburgh Medical Center (UPMC) will acquire ... and Western Pennsylvania. , The program, developed in association with efforts by the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the ... results and maintaining GMP and USP compliance. In a new webinar from METTLER ... requirements " these requirements are explained. The challenge is to determine how ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the ... care can be limited while the desire to conquer breakouts and eliminate skincare stress ... for every customer online, today released its inaugural survey on the State of Acne ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly ... professionals in the country to sit on the 2017 National Advisory Board for Allergan’s ... years Dr. Harper helped propel the clinic from a small start-up to number 78 ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... Public ... and across a variety of business channels. , While many results are clear, ... any public relations program. , When it comes to measurement, firms should always ...
Breaking Medicine News(10 mins):